av/biocon--big.svg

COM:BIOCON

Biocon

  • Stock

INR

Last Close

331.50

25/11 09:40

Market Cap

425.67B

Beta: -

Volume Today

1.24M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
3.88B
-
4.15B
7.01%
4.82B
16.25%
5.73B
18.94%
6.79B
18.41%
8.77B
29.19%
12.34B
40.67%
16.51B
33.84%
20.82B
26.11%
32.71B
57.08%
45.94B
40.44%
average payables
3.46B
-
3.88B
12.10%
4.88B
25.74%
6.43B
31.79%
8.72B
35.61%
11.02B
26.28%
12.62B
14.51%
14.20B
12.51%
15.61B
9.98%
27.96B
79.08%
50.57B
80.88%
average receivables
6.98B
-
8.47B
21.32%
10.24B
20.83%
11.94B
16.67%
13.59B
13.78%
20.04B
47.45%
12.85B
35.88%
13.66B
6.31%
31.98B
134.16%
36.54B
14.26%
49.02B
34.14%
book value per share
25.71
-
27.25
6.02%
34.43
26.34%
41.07
19.29%
43.91
6.90%
51.53
17.36%
56.63
9.90%
64.25
13.45%
70.80
10.20%
149.82
111.62%
211.34
41.06%
capex per share
-6.78
-
-7.64
12.67%
-8.30
8.58%
-6.47
22.01%
-7.77
20.04%
-12.61
62.32%
-15.51
23.01%
-14.71
5.15%
-16.16
9.86%
-14.48
10.42%
16.15
211.58%
capex to depreciation
-3.92
-
-4.15
5.79%
-4.03
2.79%
-2.75
31.83%
-2.38
13.44%
-3.33
40.00%
-3.33
0.18%
-2.44
26.57%
-2.36
3.19%
-1.55
34.40%
1.23
179.39%
capex to operating cash flow
-1.42
-
-4.35
205.57%
-1.86
57.34%
-1.19
35.85%
-1.38
16.25%
-1.29
6.65%
-1.43
10.76%
-1.51
5.21%
-1.64
8.64%
-0.93
43.04%
0.65
170.17%
capex to revenue
-0.28
-
-0.30
7.02%
-0.29
4.25%
-0.20
30.95%
-0.23
16.26%
-0.28
20.35%
-0.30
6.63%
-0.25
15.26%
-0.24
4.26%
-0.15
35.59%
0.13
184.73%
cash per share
12.77
-
9.72
23.87%
19.94
105.05%
17.90
10.22%
16.39
8.47%
9.93
39.39%
8.90
10.40%
22.22
149.73%
16.78
24.50%
32.36
92.84%
26.02
19.58%
days of inventory on hand
115.65
-
131.31
13.54%
140.08
6.68%
160.07
14.27%
160.97
0.56%
198.29
23.19%
255.13
28.66%
308.26
20.83%
307.99
0.09%
422.85
37.29%
323.26
23.55%
days payables outstanding
106.62
-
124.52
16.79%
149.86
20.35%
186.38
24.37%
223.97
20.17%
230.33
2.84%
235.44
2.22%
250.01
6.19%
215.56
13.78%
396.89
84.12%
410.10
3.33%
days sales outstanding
96.78
-
111.97
15.70%
118.88
6.17%
121.47
2.18%
131.95
8.62%
174.29
32.09%
143.05
-
166.69
16.53%
119.02
28.60%
154.12
29.50%
debt to assets
0.15
-
0.17
18.67%
0.29
67.67%
0.25
16.10%
0.23
7.53%
0.20
12.31%
0.19
5.40%
0.24
28.69%
0.25
4.31%
0.35
37.20%
0.28
18.98%
debt to equity
0.28
-
0.34
21.75%
0.61
79.88%
0.48
22.09%
0.44
8.18%
0.40
9.07%
0.40
1.91%
0.59
45.10%
0.61
3.88%
1.01
65.24%
0.80
21.16%
dividend yield
0.02
-
0.01
29.02%
0.02
73.69%
0.00
-
0.00
2.94%
0.00
1.14%
0.00
-
0.01
115.71%
earnings yield
0.05
-
0.05
6.65%
0.09
78.22%
0.03
70.84%
0.01
61.70%
0.02
134.17%
0.02
5.44%
0.02
34.68%
0.02
6.33%
0.03
61.09%
0.03
21.32%
enterprise value
86.16B
-
100.35B
16.48%
108.40B
8.02%
238.20B
119.74%
370.72B
55.63%
383.49B
3.44%
338.43B
11.75%
520.70B
53.86%
444.56B
14.62%
413.03B
7.09%
472.97B
14.51%
enterprise value over ebitda
11.62
-
13.54
16.59%
12.14
10.38%
20.96
72.69%
37.18
77.38%
25.21
32.19%
19.58
22.33%
31.08
58.70%
22.63
27.18%
15.18
32.91%
11.39
24.98%
ev to operating cash flow
15.37
-
47.63
209.96%
20.59
56.76%
37.22
80.74%
55.99
50.44%
33.21
40.68%
26.38
20.59%
44.90
70.23%
37.78
15.85%
22.30
40.99%
16.01
28.19%
ev to sales
3.02
-
3.28
8.56%
3.18
2.95%
6.19
94.55%
9.32
50.46%
7.13
23.53%
5.45
23.55%
7.47
37.11%
5.54
25.84%
3.70
33.28%
3.21
13.28%
free cash flow per share
-2.02
-
-5.88
191.38%
-3.83
34.96%
-1.04
72.91%
-2.16
107.98%
-2.85
32.24%
-4.67
63.91%
-4.94
5.73%
-6.28
27.13%
1.06
116.85%
8.55
707.77%
free cash flow yield
-0.03
-
-0.08
163.48%
-0.05
36.85%
-0.01
88.44%
-0.01
31.16%
-0.01
27.76%
-0.02
87.66%
-0.01
30.04%
-0.02
54.89%
0.01
127.40%
0.03
518.04%
graham net net
-3.25
-
-6.96
114.42%
-5.76
17.22%
-6.75
17.03%
-8.20
21.64%
-15.78
92.32%
-44.67
183.06%
-37.02
17.12%
-42.21
14.03%
-174.76
314.01%
-171.75
1.73%
graham number
45.09
-
50.42
11.82%
76.78
52.28%
69.30
9.73%
55.84
19.43%
94.18
68.66%
89.73
4.73%
94.96
5.83%
93.12
1.93%
134.82
44.78%
178.39
32.32%
income quality
1.04
-
0.34
67.62%
0.43
27.03%
0.93
116.87%
1.46
57.11%
1.15
21.19%
1.47
27.93%
1.37
6.98%
1.52
11.27%
2.88
88.93%
2.89
0.27%
intangibles to total assets
0.03
-
0.04
45.12%
0.03
16.64%
0.04
32.88%
0.06
47.43%
0.07
14.59%
0.07
8.69%
0.06
12.47%
0.06
0.47%
0.51
694.47%
0.48
7.19%
interest coverage
235.47
-
151.13
35.82%
-1.15K
859.97%
22.19
101.93%
4.11
81.50%
9.65
135.00%
17.55
81.96%
16.65
5.17%
17.02
2.22%
3.84
77.45%
5.22
35.98%
interest debt per share
7.18
-
9.28
29.14%
21.03
126.73%
19.77
6.00%
19.74
0.13%
21.07
6.72%
23.50
11.51%
38.23
62.72%
43.78
14.50%
154.61
253.18%
139.68
9.66%
inventory turnover
3.16
-
2.78
11.92%
2.61
6.27%
2.28
12.49%
2.27
0.55%
1.84
18.82%
1.43
22.28%
1.18
17.24%
1.19
0.09%
0.86
27.16%
1.13
30.81%
invested capital
0.28
-
0.34
21.75%
0.61
79.88%
0.48
22.09%
0.44
8.18%
0.40
9.07%
0.40
1.91%
0.59
45.10%
0.61
3.88%
1.01
65.24%
384.57B
38,133,101,725,320.12%
market cap
83.28B
-
93.86B
12.71%
94.88B
1.09%
222.27B
134.25%
353.08B
58.85%
366.54B
3.81%
320.37B
12.60%
485.42B
51.52%
399.72B
17.65%
246.08B
38.44%
322.54B
31.07%
net current asset value
-28M
-
-3.70B
13,114.29%
-1.22B
67.14%
-1.33B
9.13%
-1.93B
45.14%
-6.63B
244.08%
-17.36B
161.91%
-24.14B
39.10%
-25.42B
5.28%
-172.20B
577.50%
-156.17B
9.31%
net debt to ebitda
0.39
-
0.88
125.57%
1.51
72.86%
1.40
7.39%
1.77
26.17%
1.11
37.02%
1.04
6.18%
2.11
101.52%
2.28
8.39%
6.14
168.85%
3.62
40.97%
net income per share
3.51
-
4.14
17.94%
7.61
83.55%
5.20
31.69%
3.16
39.27%
7.65
142.39%
6.32
17.41%
6.24
1.28%
5.44
12.73%
5.39
0.95%
8.55
58.57%
operating cash flow per share
4.76
-
1.76
63.13%
4.47
154.54%
5.43
21.58%
5.61
3.27%
9.76
73.87%
10.84
11.06%
9.77
9.85%
9.88
1.12%
15.53
57.25%
24.70
59.00%
payables turnover
3.42
-
2.93
14.37%
2.44
16.91%
1.96
19.59%
1.63
16.78%
1.58
2.76%
1.55
2.17%
1.46
5.83%
1.69
15.98%
0.92
45.69%
0.89
3.22%
receivables turnover
3.77
-
3.26
13.57%
3.07
5.81%
3.00
2.14%
2.77
7.94%
2.09
24.29%
2.55
-
2.19
14.18%
3.07
40.06%
2.37
22.78%
research and ddevelopement to revenue
0.05
-
0.07
40.26%
0.08
23.22%
0.04
51.84%
0.01
76.80%
0.03
188.28%
0.05
90.95%
0.06
14.40%
0.06
10.56%
0.05
12.42%
0.08
52.86%
return on tangible assets
0.07
-
0.08
9.70%
0.11
34.57%
0.07
37.69%
0.04
41.62%
0.08
101.03%
0.06
29.79%
0.04
23.58%
0.03
20.50%
0.03
25.46%
0.03
37.23%
revenue per share
24.22
-
25.49
5.27%
28.91
13.40%
32.65
12.95%
33.72
3.26%
45.47
34.87%
52.46
15.36%
58.71
11.93%
67.37
14.75%
93.70
39.08%
123.39
31.68%
roe
0.14
-
0.15
11.24%
0.22
45.29%
0.13
42.74%
0.07
43.19%
0.15
106.53%
0.11
24.84%
0.10
12.98%
0.08
20.80%
0.04
53.20%
0.05
43.61%
roic
0.07
-
0.07
4.12%
0.06
20.67%
0.07
17.68%
0.03
58.88%
0.07
144.80%
0.09
37.86%
0.06
31.29%
0.07
4.70%
0.03
51.18%
0.12
281.96%
sales general and administrative to revenue
0.02
-
0.03
39.81%
0.02
25.87%
0.02
10.71%
0.03
40.58%
0.02
16.32%
0.02
12.32%
0.04
48.96%
0.02
35.81%
0.02
1.86%
0.18
661.42%
shareholders equity per share
25.71
-
27.25
6.02%
34.43
26.34%
41.07
19.29%
43.91
6.90%
51.53
17.36%
56.63
9.90%
64.25
13.45%
70.80
10.20%
149.82
111.62%
165.43
10.42%
stock based compensation to revenue
0.00
-
0.00
5.22%
0.00
93.17%
0.01
82.57%
0.01
9.39%
0.01
19.44%
0.01
72.47%
0.02
44.66%
0.02
3.00%
0.01
21.39%
0.01
44.63%
tangible asset value
29.65B
-
32.11B
8.30%
41.09B
27.99%
48.35B
17.66%
50.55B
4.54%
58.77B
16.26%
63.14B
7.44%
73.08B
15.74%
81.55B
11.59%
-41.73B
151.18%
-13.84B
66.83%
tangible book value per share
25.18
-
26.76
6.26%
34.89
30.40%
41.05
17.66%
42.84
4.36%
49.66
15.92%
53.32
7.37%
61.56
15.44%
68.47
11.23%
-35.00
151.11%
-11.58
66.92%
working capital
12.59B
-
10.08B
19.96%
23.66B
134.71%
23.69B
0.16%
20.07B
15.28%
17.85B
11.06%
13.17B
26.23%
33.90B
157.43%
45.54B
34.33%
38.23B
16.05%
-1.80B
104.70%

All numbers in INR (except ratios and percentages)